- Home
- FLYW vs BCRX Comparison
FLYW vs BCRX Comparison
Compare FLYW & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYW
- BCRX
- Stock Information
- Founded
- FLYW 2009
- BCRX 1986
- Country
- FLYW United States
- BCRX United States
- Employees
- FLYW N/A
- BCRX N/A
- Industry
- FLYW Computer Software: Prepackaged Software
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLYW Technology
- BCRX Health Care
- Exchange
- FLYW Nasdaq
- BCRX Nasdaq
- Market Cap
- FLYW 1.5B
- BCRX 1.8B
- IPO Year
- FLYW 2021
- BCRX 1994
- Fundamental
- Price
- FLYW $13.29
- BCRX $7.80
- Analyst Decision
- FLYW Buy
- BCRX Strong Buy
- Analyst Count
- FLYW 14
- BCRX 10
- Target Price
- FLYW $14.54
- BCRX $16.70
- AVG Volume (30 Days)
- FLYW 1.9M
- BCRX 2.3M
- Earning Date
- FLYW 11-06-2025
- BCRX 11-03-2025
- Dividend Yield
- FLYW N/A
- BCRX N/A
- EPS Growth
- FLYW N/A
- BCRX N/A
- EPS
- FLYW 0.05
- BCRX N/A
- Revenue
- FLYW $539,708,000.00
- BCRX $557,506,000.00
- Revenue This Year
- FLYW $20.28
- BCRX $41.37
- Revenue Next Year
- FLYW $15.67
- BCRX $7.56
- P/E Ratio
- FLYW $263.61
- BCRX N/A
- Revenue Growth
- FLYW 22.20
- BCRX 45.85
- 52 Week Low
- FLYW $8.20
- BCRX $6.02
- 52 Week High
- FLYW $23.40
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- FLYW 61.16
- BCRX 32.34
- Support Level
- FLYW $12.77
- BCRX $7.93
- Resistance Level
- FLYW $14.02
- BCRX $8.13
- Average True Range (ATR)
- FLYW 0.44
- BCRX 0.20
- MACD
- FLYW -0.01
- BCRX -0.04
- Stochastic Oscillator
- FLYW 49.63
- BCRX 3.83
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements namely a payments platform; a proprietary payment network and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.